글로벌 병원 감염 관리 시장 규모, 점유율 및 추세 분석 보고서 – 산업 개요 및 2031년까지의 예측

병원 내 감염 관리 시장 분석

기술이 확산되고 혁신적인 의료 기기의 도입이 증가함에 따라 지난 10년 동안 의료 인프라는 극적으로 변화했습니다. 지난 10년 동안 다양한 감염성 및 만성 질환의 유병률이 증가함에 따라 소독 및 살균 장비에 대한 필요성이 그 어느 때보다 더 시급해졌습니다.

병원 내 감염 관리 시장 규모

전 세계 병원 감염 관리 시장 규모는 2023년에 350억 4천만 달러로 평가되었으며, 2031년까지 745억 6천만 달러에 도달할 것으로 예상되며, 2024년에서 2031년까지의 예측 기간 동안 연평균 성장률은 9.90%입니다.

보고 범위 및 시장 세분화       

병원 내 감염 관리 시장 정의

병원 감염(HAI) 관리란 의료 환경에서 발생하는 감염을 예방하기 위한 체계적인 관행과 프로토콜을 말합니다. 여기에는 손 위생, 살균, 격리, 환자와 의료 종사자 간의 감염을 억제하기 위한 항생제의 신중한 사용과 같은 조치가 포함됩니다. 효과적인 HAI 관리로 감염 전파를 최소화하고, 환자 결과를 개선하며, 의료 비용을 절감할 수 있습니다. 지속적인 모니터링, 교육, 지침 준수는 이러한 노력의 핵심 요소입니다.

병원 내 감염 관리 시장 동향              

운전자

예측 기간 동안 병원 감염 관리 시장 성장을 촉진할 것으로 예상되는 주요 요인은 다음과 같습니다.

• 병원 내 감염(HAI) 유병률 증가

예방 조치가 부족하여 병원 감염이 증가하고 있습니다. 병원에서는 오염된 의료 장비와 장비로 인해 감염이 자주 발생하며, 병원 감염 관리 시장에 대한 수요는 더욱 가속화될 것입니다.

• 수술 시술의 증가

수년에 걸쳐, 생활 습관병, 노령 인구 증가, 척추 부상 발생률 증가로 인해 전 세계적으로 수행되는 수술 건수가 상당히 증가했으며, 이것이 시장 성장을 촉진하는 주요 요인입니다.

• 노인 인구의 증가

심혈관 질환, 암, 당뇨병 및 기타 자가면역 질환과 같은 만성 질환은 세계 인구가 고령화됨에 따라 점점 더 흔해지고 있으며, 이는 병원 감염 관리 시장 성장을 더욱 촉진할 것으로 예상됩니다.

기회

또한, 일회용  의료용 부직포  와 장비의 채택이 확대됨에 따라 향후 몇 년 안에 병원 내 감염 관리 시장이 성장할 수 있는 잠재적 기회가 제공될 것으로 추산됩니다.

제약/도전

반면, 내시경 재처리 비용 증가와 선진국에서의 부적절한 환불은 목표 기간 동안 병원 감염 관리 시장의 성장을 더욱 저해할 것으로 예상됩니다. 그러나 병원 감염 관리 절차와 관련된 어려움은 가까운 미래에 병원 감염 관리 시장의 성장을 더욱 어렵게 만들 수 있습니다.

This hospital acquired infection control market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the hospital acquired infection control market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Covid-19 Impact on Hospital Acquired Infection Control Market

The pandemic of COVID-19 has had a huge impact on the hospital acquired infection control market. The pandemic has wreaked havoc on healthcare systems around the world, with hospitals becoming overburdened as the number of patients continues to rise. Temporary hospitals were also established to handle the increasing number of cases. As a result of the increasing cases of hospital acquired infection in hospital settings, the spread of COVID-19 has resulted in an increase in demand for HAI services. However, in the aftermath of the pandemic, the severe consequences of COVID-19, such as hospitalisation, may help the hospital-acquired infection control industry gain traction in the coming years.

Global Hospital Acquired Infection Control Market Scope

The hospital acquired infection control market is segmented on the basis of product, application, technology, disease and end users. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• Sterilizers
• Disinfectors
• Endoscope Reprocessors
• Microbial Testing Instruments
• Reagents
• Consumables
• Disinfectants
• Infection Prevention and Surveillance Software
• Others

On the basis of product, the hospital acquired infection control market is segmented into sterilizers, disinfectors, endoscope reprocessors, microbial testing instruments, reagents, consumables, disinfectants, infection prevention and surveillance software and others. Sterilizers have been further sub segmented into heat sterilization equipment, low temperature sterilization equipment, radiation sterilization equipment and others. Heat sterilization equipment is further sub segmented into moist heat sterilization equipment and dry heat sterilization equipment. Disinfectors have been further sub segmented into washer disinfector and flusher disinfector. Endoscope reprocessors have been further sub segmented into single basin endoscopic reprocessors and dual basin endoscopic reprocessors. Microbial testing instruments have been further sub segmented into automated microbial identification systems, polymerase chain reaction (PCR) instruments, mass spectrometers, microarrays, polystainers, flow cytometers and others. Disinfectants have been further sub segmented into type and formulation. Type has been further sub segmented into hand disinfectants, skin disinfectants, instrument disinfectants and surface disinfectants/disinfectant robots. Formulation has been further sub segmented into disinfectant wipes, disinfectant liquids and disinfectant sprays.

Application

• Disease Testing
• Drug-Resistance Testing

On the basis application, the hospital acquired infection control market is segmented into disease testing and drug-resistance testing.

Technology

• Phenotypic Methods
• Genotypic Methods

On the basis of technology, the hospital acquired infection control market is segmented into phenotypic methods and genotypic methods. Phenotypic methods has been further sub segmented into phage-based assays, colorimetric methods and nitrate reductase assay. Genotypic methods has been further sub segmented into DNA sequencing, solid-phase hybridization techniques, polymerase chain reaction (PCR) techniques and microarrays.

Disease

• Hospital Acquired Pneumonia
• Bloodstream Infections
• Surgical Site Infections
• Gastrointestinal Infections
• Urinary Tract Infection
• Others

On the basis of disease, the hospital acquired infection control market is segmented into hospital acquired pneumonia, bloodstream infections, surgical site infections, gastrointestinal infections, urinary tract infections (UTI) and others.

End Users

• Hospitals
• ICUs
• Ambulatory Surgical
• Diagnostic Centers
• Nursing Homes
• Maternity Centers
• Others

On the basis of end users, the hospital acquired infection control market is segmented into hospitals, intensive care units (ICUs), ambulatory surgical, diagnostic centers, nursing homes, maternity centers and others.

Hospital Acquired Infection Control Market Regional Analysis

The hospital acquired infection control market is analysed and market size insights and trends are provided by country, product, application, technology, disease and end users as referenced above.

The countries covered in the hospital acquired infection control market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the hospital acquired infection control market due to the rise in the major healthcare facilities and authorities on the prevention and spread of any infections originating from different healthcare facilities. Furthermore, the increase in the awareness of hospital acquired infection will further boost the growth of the hospital acquired infection control market in the region during the forecast period.

Asia-Pacific is projected to observe significant amount of growth in the hospital acquired infection control market due to the rise in the incidence of hospital acquired infections and advancing healthcare infrastructure in low and middle-income countries. Moreover, the newborns in the advancing countries are at a higher risk of contracting healthcare-associated infections than in developed countries which is further anticipated to propel the growth of the hospital acquired infection control market in the region in the coming years.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The hospital acquired infection control market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for hospital acquired infection control market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the hospital acquired infection control market. The data is available for historic period 2010-2020.

Hospital Acquired Infection Control Market Share

병원 인수 감염 관리 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 프로그램 우세입니다. 제공된 위의 데이터 포인트는 병원 인수 감염 관리 시장과 관련된 회사의 초점에만 관련이 있습니다.

 시장에서 운영되는 병원 감염 관리 시장 리더는 다음과 같습니다.

• 올림푸스 주식회사(일본)
• 캔텔 메디컬(미국)
• 게팅게 AB(스웨덴)
• STERIS plc (미국)
• 벨리메드(스위스)
• STEELCO SpA(이탈리아)
• ASP(미국)
• BD(미국)
• Crosstex International, Inc. (미국)
• 다이버시 주식회사(미국)
• MMM 그룹(미국)
• 3M(미국)
• bioMérieux SA(프랑스)
• Sterigenics US, LLC(미국)
• 세페이드(미국)
• 덴츠플라이 시로나(미국)
• Mindray Bio-Medical Electronics Co., Ltd (중국)
• Randox Laboratories Ltd. (영국)
• Ortho Clinical Diagnostics (미국)
• 노바 바이오메디컬(영국)
• 시스멕스 주식회사(일본)

병원 내 감염 관리 시장의 최신 동향

• 2021년 9월, Sodexo는 Protecta Plus 프로그램을 통해 병원 감염을 통제하기 위해 미국에서 Ecolab과의 파트너십을 확대했습니다. 이 프로그램은 Ecolab의 Bioquell 과산화수소 증기 기술을 활용하여 병원 및 의료 시설의 감염 위험을 줄이기 위해 만들어졌습니다.

SKU-24749